Physician profile
Sophia Kim
NPI 1285154922
$69,620.20
in general payments reported to CMS, 2019-2025
26 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $350 · 2022: $671 · 2023: $448 · 2024: $221 · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62K · Travel and Lodging: $3,617 · Food and Beverage: $3,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61,970.00 |
| Travel and Lodging | $3,616.79 |
| Food and Beverage | $3,012.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $67,854.18 | 2021-2025 | |
| Glaxosmithkline, LLC. | $495.97 | 2021-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Galderma Laboratories, L.P. | $268.02 | 2022-2024 | |
| Mannkind Corporation | $137.02 | 2021-2022 | |
| Amgen INC. | $115.37 | 2022-2023 | Evenity, Prolia |
| Allergan, INC. | $96.21 | 2021-2022 | |
| Novo Nordisk INC | $91.08 | 2023-2025 | Wegovy |
| Lilly USA, LLC | $77.14 | 2021-2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $73.78 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $59.84 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $54.30 | 2025 | Angiojet Ultra 5000a |
| Abbott Laboratories | $37.92 | 2022-2024 | Cardiomems |
| Medtronic, INC. | $29.26 | 2022 | |
| Grifols USA, LLC | $28.94 | 2021 | |
| Amarin Pharma, INC. | $28.90 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.95 | 2023 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $17.63 | 2023 | Yupelri |
| Celgene Corporation | $17.25 | 2024 | Reblozyl |
| Zealand Pharma US, INC. | $15.70 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.42 | 2023 | Horizant |
| Mallinckrodt Hospital Products INC. | $15.00 | 2022 | |
| Genzyme Corporation | $14.93 | 2021 | |
| Intra-Sana Laboratories | $14.90 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Tolmar, INC. | $14.78 | 2023 | |
| Currax Pharmaceuticals LLC | $14.08 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.